Cantor Fitzgerald Assumes, Upgrades Zimmer Biomet (ZBH) to Overweight

Cantor Fitzgerald assumed and upgraded Zimmer Biomet (NYSE: ZBH) from Neutral to Overweight with a price target of $140.00 (from $137.00).

For an analyst ratings summary and ratings history on Zimmer Biomet click here. For more ratings news on Zimmer Biomet click here.

Shares of Zimmer Biomet closed at $124.92 yesterday.

You May Also Be Interested In

• Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
• Science Applications (SAIC) PT Raised to $140 at Jefferies
• Edison International (EIX) PT Lowered to $63 at UBS